oltipraz has been researched along with caffeine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berthou, F; Coles, B; Glaise, D; Guillouzo, A; Ketterer, B; Lagadic-Gossman, D; Langouët, S; Mahéo, K; Morel, F | 1 |
| Choo, EF; Mayo, G; Shyr, Y; Sofowora, GG; Wilkinson, GR | 1 |
2 other study(ies) available for oltipraz and caffeine
| Article | Year |
|---|---|
Effects of administration of the chemoprotective agent oltipraz on CYP1A and CYP2B in rat liver and rat hepatocytes in culture.
Topics: Aflatoxin B1; Animals; Anticarcinogenic Agents; Caffeine; Cells, Cultured; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP2B1; Liver; Male; Pyrazines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Thiones; Thiophenes | 1997 |
In vivo inhibition of human CYP1A2 activity by oltipraz.
Topics: Adult; Antineoplastic Agents; Caffeine; Cytochrome P-450 CYP1A2 Inhibitors; Enzyme Inhibitors; Female; Humans; Male; Methylation; Pyrazines; Theophylline; Thiones; Thiophenes | 2001 |